X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12447) 12447
Book Review (3259) 3259
Publication (527) 527
Book Chapter (59) 59
Newsletter (53) 53
Conference Proceeding (27) 27
Dissertation (11) 11
Book / eBook (9) 9
Magazine Article (6) 6
Data Set (1) 1
Newspaper Article (1) 1
Paper (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (10304) 10304
humans (7266) 7266
male (5250) 5250
animals (4506) 4506
female (3376) 3376
angiotensin-converting enzyme inhibitors - therapeutic use (3268) 3268
converting enzyme-inhibition (3182) 3182
hypertension (2776) 2776
rats (2660) 2660
angiotensin-converting enzyme inhibitors - pharmacology (2533) 2533
middle aged (2434) 2434
cardiac & cardiovascular systems (2303) 2303
blood pressure - drug effects (2067) 2067
peripheral vascular disease (2057) 2057
hypertension - drug therapy (1982) 1982
pharmacology & pharmacy (1801) 1801
adult (1788) 1788
aged (1723) 1723
angiotensin (1698) 1698
blood-pressure (1630) 1630
abridged index medicus (1612) 1612
urology & nephrology (1422) 1422
captopril (1420) 1420
converting-enzyme-inhibition (1289) 1289
renin-angiotensin system (1269) 1269
antihypertensive agents - therapeutic use (1182) 1182
hypertension - physiopathology (1161) 1161
ace inhibitors (1135) 1135
blood pressure (1125) 1125
renin-angiotensin system - drug effects (1110) 1110
angiotensin-converting enzyme inhibitors (1087) 1087
angiotensin-converting enzyme (1000) 1000
risk factors (988) 988
enalapril (982) 982
heart failure (973) 973
enzymes (913) 913
medicine, general & internal (898) 898
treatment outcome (896) 896
mortality (841) 841
physiology (840) 840
heart failure - drug therapy (825) 825
myocardial-infarction (823) 823
angiotensin receptor antagonists (767) 767
renin-angiotensin system - physiology (759) 759
medicine & public health (756) 756
angiotensin ii (754) 754
diabetes (748) 748
time factors (744) 744
drug therapy (741) 741
drug therapy, combination (725) 725
angiotensin-ii (713) 713
proteinuria (711) 711
captopril - pharmacology (696) 696
double-blind method (692) 692
nephropathy (660) 660
research (659) 659
hemodynamics - drug effects (657) 657
heart-failure (654) 654
angiotensin-converting enzyme inhibitors - administration & dosage (640) 640
hypertension - complications (635) 635
rats, sprague-dawley (634) 634
antihypertensive agents - pharmacology (625) 625
bradykinin (618) 618
angiotensin converting enzyme (613) 613
renin - blood (610) 610
kidney - drug effects (603) 603
endocrinology & metabolism (587) 587
heart failure - physiopathology (584) 584
physiological aspects (584) 584
renin (578) 578
disease (576) 576
dose-response relationship, drug (573) 573
rats, wistar (553) 553
left-ventricular dysfunction (544) 544
progression (544) 544
enalapril - pharmacology (520) 520
angiotensin-converting enzyme inhibitors - adverse effects (519) 519
diabetic nephropathy (517) 517
disease models, animal (508) 508
expression (505) 505
losartan (502) 502
disease progression (501) 501
enalapril - therapeutic use (499) 499
cardiology (497) 497
system (496) 496
mice (488) 488
analysis (486) 486
hypertrophy (485) 485
rats, inbred shr (480) 480
peptidyl-dipeptidase a - metabolism (476) 476
nitric-oxide (475) 475
acute myocardial-infarction (471) 471
care and treatment (471) 471
angiotensin ii type 1 receptor blockers - therapeutic use (470) 470
heart rate - drug effects (466) 466
health aspects (462) 462
captopril - therapeutic use (459) 459
therapy (459) 459
cardiovascular disease (458) 458
kidney (455) 455
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12174) 12174
German (103) 103
French (80) 80
Japanese (64) 64
Spanish (60) 60
Russian (45) 45
Chinese (24) 24
Korean (6) 6
Portuguese (6) 6
Italian (5) 5
Polish (3) 3
Turkish (3) 3
Hungarian (2) 2
Danish (1) 1
Hebrew (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Kidney International, ISSN 0085-2538, 03/2012, Volume 81, Issue 5, pp. 494 - 501
Journal Article
Journal of the American Society of Nephrology, ISSN 1046-6673, 12/2009, Volume 20, Issue 12, pp. 2641 - 2650
Aldosterone promotes glomerular and tubular sclerosis independent of angiotensin II in animal models of diabetic nephropathy. Most human studies testing the... 
PRONE HYPERTENSIVE-RATS | VASCULAR INJURY | CONTROLLED-TRIAL | CARDIOVASCULAR OUTCOMES | ALDOSTERONE ANTAGONISM | HEART-FAILURE | RENAL OUTCOMES | UROLOGY & NEPHROLOGY | BLOOD-PRESSURE CONTROL | CHRONIC KIDNEY-DISEASE | ANTIHYPERTENSIVE TREATMENT | Angiotensin II Type 1 Receptor Blockers - adverse effects | Spironolactone - administration & dosage | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Diabetic Nephropathies - drug therapy | Hypertension - drug therapy | Male | Diabetic Nephropathies - physiopathology | Lisinopril - adverse effects | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Adult | Female | Bicarbonates - blood | Blood Pressure - drug effects | Albuminuria - urine | Drug Therapy, Combination | Hypertension - urine | Spironolactone - adverse effects | Angiotensin II Type 1 Receptor Blockers - administration & dosage | Lisinopril - administration & dosage | Diabetic Nephropathies - urine | Mineralocorticoid Receptor Antagonists - administration & dosage | Double-Blind Method | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Creatinine - urine | Hypertension - physiopathology | Albuminuria - drug therapy | Losartan - adverse effects | Potassium - blood | Renin-Angiotensin System - drug effects | Losartan - administration & dosage | Index Medicus | Clinical Research
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2004, Volume 351, Issue 20, pp. 2058 - 2068
Journal Article
Journal Article
BMJ, ISSN 0959-8138, 7/2011, Volume 343, Issue 7818, pp. 298 - 298
Objective To compare the effects on proteinuria and blood pressure of addition of dietary sodium restriction or angiotensin receptor blockade at maximum dose,... 
RESEARCH | Enzymes | Nephrology | Sodium | Internal medicine | Sodium restricted diets | Enzyme inhibition | Blood pressure | Dietary sodium | Angiotensin receptors | Proteinuria | ANTIPROTEINURIC EFFICACY | GLOMERULAR-FILTRATION-RATE | MEDICINE, GENERAL & INTERNAL | TERM ANTIHYPERTENSIVE TREATMENT | CARDIOVASCULAR-DISEASE | ACE-INHIBITION | CHRONIC KIDNEY-DISEASE | DIABETIC NEPHROPATHY | HYPERTENSIVE PATIENTS | CHRONIC-RENAL-FAILURE | ALDOSTERONE SYSTEM | Kidney Diseases - physiopathology | Valsartan | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Middle Aged | Sodium Chloride, Dietary - administration & dosage | Male | Proteinuria - prevention & control | Lisinopril - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Hypertension - prevention & control | Female | Blood Pressure - drug effects | Blood Pressure - physiology | Kidney Diseases - complications | Drug Therapy, Combination | Double-Blind Method | Valine - analogs & derivatives | Treatment Outcome | Combined Modality Therapy | Hypertension - physiopathology | Proteinuria - physiopathology | Cross-Over Studies | Diet, Sodium-Restricted - methods | Tetrazoles - therapeutic use | Valine - therapeutic use | Patient Compliance | Chronic Disease | Kidney diseases | ACE inhibitors | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Circulation, ISSN 0009-7322, 04/2008, Volume 117, Issue 17, pp. 2262 - 2269
Background - The excess in cardiovascular risk in patients with rheumatoid arthritis provides a strong rationale for early therapeutical interventions. In view... 
Angiotensin-converting enzyme inhibitors | Rheumatoid | Arthritis | Inflammation | Endothelium | endothelium | angiotensin-converting enzyme inhibitors | CARDIAC & CARDIOVASCULAR SYSTEMS | CARDIOVASCULAR EVENTS | RABBIT MODEL | RISK | ENDOTHELIAL FUNCTION | EUROPEAN-SOCIETY | arthritis, rheumatoid | TUMOR-NECROSIS-FACTOR | WORKING GROUP | inflammation | PERIPHERAL VASCULAR DISEASE | DYSFUNCTION | HYPERTENSION | CORONARY-ARTERY-DISEASE | Oligonucleotide Array Sequence Analysis | Vasculitis - epidemiology | Humans | Middle Aged | Male | Vasculitis - prevention & control | Arthritis, Rheumatoid - complications | Atherosclerosis - epidemiology | Ramipril - administration & dosage | Adult | Female | Umbilical Veins - cytology | Endothelial Cells - physiology | Risk Factors | Arthritis, Rheumatoid - epidemiology | Cells, Cultured | Treatment Outcome | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Cross-Over Studies | Endothelial Cells - cytology | Biomarkers | Renin-Angiotensin System - drug effects | Aged | Oxidative Stress - drug effects | Vasodilation - drug effects | Atherosclerosis - prevention & control | Endothelial Cells - drug effects | Prevention | Rheumatoid arthritis | Angiotensin converting enzyme | Physiological aspects | Ramipril | Dosage and administration | Research | Cardiovascular diseases | Health aspects | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Circulation Research, ISSN 0009-7330, 11/2010, Volume 107, Issue 11, pp. 1364 - 1373
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 23, pp. 2832 - 2841
Abstract Background Cardiac allograft vasculopathy (CAV) remains a leading cause of mortality after heart transplantation (HT). Angiotensin-converting enzyme... 
Cardiovascular | Internal Medicine | cardiac allograft vasculopathy | microcirculation | coronary physiology | CARDIAC & CARDIOVASCULAR SYSTEMS | PERIPHERAL-BLOOD | DILTIAZEM | INVASIVE ASSESSMENT | ENDOTHELIAL PROGENITOR CELLS | FLOW RESERVE | RAMIPRIL | INTRAVASCULAR ULTRASOUND | DYSFUNCTION | CORONARY-ARTERY-DISEASE | Coronary Vessels - diagnostic imaging | Graft Rejection - drug therapy | Vascular Resistance | Prospective Studies | Coronary Circulation - physiology | Double-Blind Method | Follow-Up Studies | Coronary Vessels - physiopathology | Humans | Ultrasonography, Interventional | Heart Transplantation - adverse effects | Treatment Outcome | Graft Rejection - diagnosis | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Ramipril - administration & dosage | Coronary Angiography | Time Factors | Heart | Enzymes | Medical colleges | Mortality | Angiotensin | Transplantation | Cardiology | Heart diseases | ACE inhibitors | Cardiovascular agents | Angiotensin converting enzyme | Physiological aspects | Angiotensin-converting enzyme inhibitors | Therapy | Pediatrics | Oxidative stress | Transplants & implants | Angiography | Syngeneic grafts | Cardiovascular disease | Vascular diseases | Allografts | Enzyme inhibitors | Peptidyl-dipeptidase A | Xenografts | Ultrasonography | Physiology | Inhibition | Safety | Drug dosages | Hypertension | Cytomegalovirus | Effectiveness | Medical imaging | Heart transplantation | Coronary artery | Group dynamics | Patients | Survival | Flow | Inhibitors | Converting | Coronary vessels | Stem cells | Cells (biology) | Microvasculature | Adults | Health risk assessment | Index Medicus | Abridged Index Medicus | Microcirculation | Coronary physiology | Cardiac allograft vasculopathy
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2004, Volume 351, Issue 19, pp. 1952 - 1961
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2014, Volume 63, Issue 22, pp. 2421 - 2428
Journal Article